Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Nightstar TherapeuticsProteon TherapeuticsAtara BiotherapeuticsAvrobioOsiris Therapeutics
SymbolNASDAQ:NITENASDAQ:PRTONASDAQ:ATRANASDAQ:AVROOTCMKTS:OSIR
Price Information
Current Price$25.41$23.04$7.53$13.51$18.99
52 Week RangeN/AHoldBuyBuyN/A
Analyst Ratings
Consensus RecommendationN/AHoldBuyBuyN/A
Consensus Price TargetN/AN/A$29.88$32.07N/A
% Upside from Price TargetN/AN/A296.75% upside137.38% upsideN/A
Trade Information
Market Cap$852.25 million$510.12 million$479.11 million$480.65 million$655.69 million
Beta2.840.62.512.23N/A
Average Volume185,8081,113,217819,715365,094202,293
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.89 per share($0.06) per share$5.37 per share$5.87 per shareN/A
Price / BookN/AN/AN/AN/AN/A
Profitability
Net Income$-36,860,000.00$-20,730,000.00$-290,980,000.00$-72,960,000.00N/A
EPS($1.26)($1.15)($5.67)($2.66)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-30.89%N/A-103.42%-49.28%N/A
Return on Assets (ROA)-27.65%-118.68%-89.08%-45.81%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.05%N/AN/A
Current Ratio8.54%5.98%7.43%13.96%N/A
Quick Ratio8.54%5.98%7.43%13.96%N/A
Ownership Information
Institutional Ownership Percentage32.83%23.03%N/A68.29%0.28%
Insider Ownership PercentageN/A45.70%7.00%4.70%43.40%
Miscellaneous
Employees471732149N/A
Shares Outstanding33.54 million22.18 million58.57 million36.03 million34.53 million
Next Earnings DateN/A5/6/2020 (Estimated)5/14/2020 (Estimated)5/11/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel